MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4

73Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Overexpression of microRNA-182 (miR-182) is found in various human cancers, including non-small cell lung cancer (NSCLC). Our aim is to investigate the association of miR-182 expression with the sensitivity of NSCLC to cisplatin.Methods: TaqMan RT-PCR or Western blot assay was performed to detect the expression of mature miR-182 and programmed cell death 4 (PDCD4) protein. miR-182 and (or) PDCD4 depleted cell lines were generated using miR-182 inhibitor and (or) siRNA. The viabilities of treated cells were analyzed using MTT assay.Results: The expression level of miR-182 in A549 cell line was significantly higher than that in NHBE cell line (p < 0.01). Transfection of miR-182 inhibitor induced sensitivity of A549 cells to cisplatin. A549 cells transfected with PDCD4 siRNA became more resistant to cisplatin therapy. We found an increase PDCD4 protein level following the transfection of miR-182 inhibitor using Western blot analysis. In addition, the enhanced growth-inhibitory effect by miR-182 inhibitor was weakened after the addition of PDCD4 siRNA.Conclusions: The results of the present study demonstrated that overexpression of miR-182 may involve in chemoresistance of NSCLC cells to cisplatin by down-regulating PDCD4.The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1793467320130186. © 2014 Ning et al.; licensee BioMed Central Ltd.

References Powered by Scopus

Cancer statistics, 2014

11522Citations
N/AReaders
Get full text

MicroRNA signatures in human cancers

7007Citations
N/AReaders
Get full text

Targeting multidrug resistance in cancer

3226Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role and mechanisms of action of microRNAs in cancer drug resistance

523Citations
N/AReaders
Get full text

The microRNA-183 cluster: The family that plays together stays together

165Citations
N/AReaders
Get full text

miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer

122Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ning, F. ling, Wang, F., Li, M. li, Yu, Z. shun, Hao, Y. zhang, & Chen, S. shui. (2014). MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagnostic Pathology, 9(1). https://doi.org/10.1186/1746-1596-9-143

Readers over time

‘14‘15‘16‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

76%

Lecturer / Post doc 2

10%

Researcher 2

10%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

41%

Biochemistry, Genetics and Molecular Bi... 9

41%

Medicine and Dentistry 3

14%

Pharmacology, Toxicology and Pharmaceut... 1

5%

Save time finding and organizing research with Mendeley

Sign up for free
0